Noile-Immune Biotech Inc. announced a private placement of 256,871 common shares at a price of ¥3,893 per share for the gross proceeds of ¥999,998,803 with existing investor BINEX Co., Ltd. (KOSDAQ:A053030) on March 12, 2021. The investor now holds 455,565 shares and 5.8% stake in the company. The transaction was approved by the board of directors of investor.

On the same date, the company has received its first tranche.